Member Info for ShareSting

It would appear that some commentators here either don’t understand the Medical Industry or are deliberately trying to scare investors this evening.

The treatment ****tail announced today, is excellent news for the 24% of critically ill it helps.

Anyone saying thanks to the treatments announcement today and vaccines, SNG001 has no role is clearly stupid or not researched!

SNG001 is a broad spectrum anti viral drug. The use of this drug will step change medicine. It will be seen as one of the biggest achievements in medicine this year. This statement is based on similar results to Phase 2.

The RNS will be submitted to the market when it is worthy of delivering. Synairgen don’t RNS every minor achievement... they focus on the significant wins.

IMO Big Wins will land through this month and beyond. THAT IS WHY I AM INVESTED HERE.

Ignore the trolls. Make your own mind up based in data and facts.

I just want to wish everyone a safe and Happy Christmas.
Let’s hope SNG001 starts to make a difference in hospitals across the U.K. and world.

I have no doubt the team at Synairgen will be work many extra hours over the Christmas period and for that I am very very grateful.

Good luck with your investment throughout 2021.

Are you guys seeing the delayed trades from yesterday.
Some volume again !

Afternoon
With well over 10% of company shares traded this week, I’m expecting to see another TR1 land from a overseas II.

As I noted yesterday, I also believe we will hear from the company again soon. I doubt the team at Synairgen will have much down time this Christmas as the coordinate the 20 country trial and set up for further trials in America.

This company is now global, but the MCAP doesn’t reflect this as yet. Still a strong buy, even at this price .. for me !

GLA

Two other points

7. I am expecting another TR1.
8. Please please please find time to post the Covid Home Trial link on your social media and tell family and friends about it www.covidtrialathome.com

Thank you

Loxl2 inhibitor programme.

Hello all
I am still very much invested in Synairgen.
The team in Southampton have done an outstanding job achieving FDA Phase 3, wow what an achievement!

I am expecting further updates from the business on a number of fronts :

1. Activ-2 USA Home Trials
2. U.K. Home trials final person dosed
3. Potential of licence deals for Asia / India
4. Phase 3 first dose
5. Ongoing partnership discussions (probably with US based Pharma )
6. Maybe an update on Australia drug progress.

Synairgen is becoming internationally recognised and as a result of the FDA backing, has become extremely more valuable.

I will be backing the company to the “end game” and with last weeks announcement it looks like we have made the finals !!

Good luck all genuine holders and especially good luck to some of the old school here !!

There is no current delay to launching Phase3 in Q4.

I believe The new nebuliser will have had additional testing requirements to meet FDA sign off. This will have taken labtime to complete.

Phase3 trials need to be 100% perfect at the start, so the Drug sign off can be expedited when the end point is reached.

This broad spectrum anti virus drug has multiple use application and will significantly change hospital process going forward.

Phase3 FDA sign off will be monumental for Synairgen.

I am expecting news within 5 working days.

Good luck

Wow the level of insults on this board today towards the dynamic forward think hugely knowledgeable management team at Synairgen is quite remarkable. Are these people invested or trying to short the price ?

Phase 3 is the biggest and most important step for Synairgen. Achieving FDA approval is a milestone most small caps dream of. It is about to become reality here

Fluctuating share price doesn’t concern me. I know what potential this drug has once approved and the associated value.

It is clear some trader are frustrated. It is clear some trolls are talking down the company. That is up to them. But reality and truth will always shine through.

Ok so Parsley has no evidence to back up his spamming of this board. So yes we do need to wait for FDA and MHRA approval and there is no fast track available.
I head both MHRA and FDA are being very supportive, more than can be said for some so called investors here today.

Parsley
I take it you can’t demonstrate where the MHRA and FDA have ripped up their rules.
If you do have a fast path around the MHRA and FDA please urgently contact Sue at Synairgen as I’m sure they would be glad to hear from you and your expertise.

Parsley
Please share with us what rule book has been ripped up.
The MHRA and FDA are as demanding as ever. Who has told you the opposite??

Any one saying “just to slow” doesn’t understand how quickly and nimble this company is moving.
What they are about to achieve in 2020 would take some majors 5 years.

The FDA are rightly wanting the Phase3 to be correct with all data points and protocols 100%. This will expedite the approval process.

Synairgen are developing a broad spectrum anti viral which will be worth billions.

Just to slow investors in Synairgen need to investigate and understand this market a little more.

Major news is on its way.

It would appear that volume is slowing.
The same thing happens when we were at 32p.
There is a clear role for a new broad spectrum anti viral drug both in the UK and across the world. Most investors know this and will be happy to wait for next years results.

As I have mentioned before. The FDA are making our Phase 3 water tight. We need America and boy do they need us.
I’m expecting news next week. A nice chunky RNS.

Looks like a few people need to research this company a bit more. So many obvious trolls active. Quite sad really.

Why bother the company with questions when they can only answer through an RNS when ready.

If you are invested you would realise what potential this drug has a broad spectrum anti viral. This is clearly not just a Covid19 play. Having said that this drug will help People around the world suffering from CoronVirus.

The team at Synairgen are cramming over 12 months work into 2 months. It’s clearly a huge ask for such a small company, however they are receiving amazing support.

Good luck genuine holders !

There are no delays to the Phase3 trials, start date is Q4.
The amount of information Synairgen has had to provide to the FDA is immense for both drug and nebuliser.
This is necessary as the Phase2 took place in UK so America are starting from zero up. The team are doing a fantastic job and it sounds like the FDA are supporting every step.

As for the UK there is no excuse for any delay. As we have found over the last 8 months, it would appear Synairgen are being slowed down by Government agencies. It is shocking and the main reason Synairgen is now focusing outside the UK.

We should receive and update very soon.

I read at the weekend someone called Myles sold out last week. Another trader gone, which is good news as well.

This is getting to the exciting stage of news flow now !

Good luck genuine holders.

People need to seriously understand what the team are working on. Setting up a Phase 3 is massive huge gigantic.
Major pharmaceuticals take on average 6-12 months to run a Phase 3.

We have the drug and nebuliser and combination usage protocols to approve.

Please stop bashing the team at Southampton. This is an investment not a quick buck trade.

Why not do some good and message the Home Trials to friends and family and post it on social media.

Let’s discuss SNG. My thoughts

1. We know the company is planning to start production of 100k doses per month in Q1.

2. P3 is not delayed. It plans to start in Q4. The complexity of running a phase 3 trial in one country is massive. Try 20! Gzzz some investors are so detached from reality. We have a drug and nebuliser and the combination dosing to get formally approved for Phase 3. The good news is once approved this will expedite the actual drug approval process post trial.
3. Q4
4. Last update was mid 40’s and increasing daily. It will end when fully recruited. Are you carrying a link on your social media ??
5. We know this is being handled by a 3rd party. We will be made aware of any price sensitive discussions.
6. EUA is down to the individual country. Every country is different. Search the country you are interested in on Google. Why not... ask your MP !
7. Limited according to RM
8. Me and many many others.

You seem so negative about SNG and the management.

I think you should maybe try an understanding just how challenging setting up a phase 3 study is. Then you might understand why the team in Southampton are working so bloody hard !!!

Synairgen is gearing itself up to supply America.
Look at the recent appointments.
When we get FDA clearance for Phase 3 hospital trials and Home trials this will be the most significant day for this brilliant company and amazing cross spectrum anti viral drug.
Very exciting weeks ahead.

America needs SNG001 and we need America !